Northwire Canada EditionSunday, October 18, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%
Earnings

Neupath Health to release Q3 2025 results Nov. 13

By The Northwire Desk — AI Analysis Oct 27, 2025 · 16:12 NPTH · 0.39 Neupath Health Inc
NPTH · Price

Executive Summary

  • Neupath Health Inc. will release its financial results for the third quarter of 2025 before market open on Thursday, November 13, 2025.
  • The company will host a live investor webinar featuring CEO Joe Walewicz to discuss the Q3 results, operations, and strategic outlook.
  • The webinar will be hosted by Martin Gagel of Market Radius Research and will include a presentation and Q&A session.

Key Details

  • Reporting Period: Third Quarter 2025.
  • Release Timing: Before market open on Thursday, Nov. 13, 2025.
  • Webinar Host: Martin Gagel, Radius Research (former top-ranked technology analyst).
  • Webinar Date and Time: Thursday, Nov. 13, 2025, at 10 a.m. ET / 7 a.m. PT.
  • Webinar Format: Live presentation and Q&A session with CEO Joe Walewicz.
  • Company Operations: Neupath operates a network of healthcare clinics in Ontario and Alberta focusing on chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions. The company also provides workplace health services, independent medical assessments, and contract research services to pharmaceutical and biotechnology companies.

Notable Quotes

  • No direct quotes from the CEO or management were included in the release text.
Read the original news release →

More from Neupath Health Inc

May 14, 2026 · 07:30

NeuPath Health Confirms Growth Trajectory Under New CEO Despite Margin Compression and Debt Settlement Risks

Earnings Apr 01, 2026 · 07:30

NEUPATH HEALTH ANNOUNCES PROPOSED SHARES FOR DEBT SETTLEMENT

Financings Mar 26, 2026 · 07:30

NEUPATH HEALTH REPORTS FOURTH QUARTER AND YEAR-END 2025 RESULTS

Earnings Mar 17, 2026 · 17:02

Neupath Health to release 2025 results March 26

Earnings Jan 26, 2026 · 17:51

Neupath Health appoints Lemieux as CEO

Other Jan 26, 2026 · 07:30

NEUPATH HEALTH ANNOUNCES EXECUTIVE LEADERSHIP CHANGES AS PART OF PLANNED TRANSITION, PRE-ANNOUNCES STRONG 2025 RESULTS

Other